Home
About Us
Company Profile
HIstory
Culture
Honor
Products
Cardiovascular series
Psychiatry series
Hepatobiliary, Gastroenterology Series
Respiratory series
Anti-infective virus series
Other series
Large Infusion Series
Huabao Tong Series
Active Pharmaceutical Ingredient Series
R&D
Academician Expert Workstation
Medical Research and Industry Alliance
News
General News
Party group dynamics
Employee activity
HR
Talent Strategy
Company recruitment
Contact us
中文版
Date:
29 Aug,2022
5 Month, Acquiring Tangshan Bohai Pharmaceutical Co., Ltd.
Previous page
2009
2004
Next page
Related Recommendations
2021/02/07
Active pharmaceutical ingredients and generic drugs become two major monitoring priorities.
2021/03/01
Wanbande Pharmaceutical Group Named Among "Top 20 Enterprises in Taizhou City"
Wanbande Pharmaceutical Group Takes Center Stage at the 75th National Pharmaceutical Expo